AFF3_HUMAN - dbPTM
AFF3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID AFF3_HUMAN
UniProt AC P51826
Protein Name AF4/FMR2 family member 3
Gene Name AFF3
Organism Homo sapiens (Human).
Sequence Length 1226
Subcellular Localization Nucleus.
Protein Description Putative transcription activator that may function in lymphoid development and oncogenesis. Binds, in vitro, to double-stranded DNA..
Protein Sequence MDSFDLALLQEWDLESLCVYEPDRNALRRKERERRNQETQQDDGTFNSSYSLFSEPYKTNKGDELSNRIQNTLGNYDEMKDFLTDRSNQSHLVGVPKPGVPQTPVNKIDEHFVADSRAQNQPSSICSTTTSTPAAVPVQQSKRGTMGWQKAGHPPSDGQQRATQQGSLRTLLGDGVGRQQPRAKQVCNVEVGLQTQERPPAMAAKHSSSGHCVQNFPPSLASKPSLVQQKPTAYVRPMDGQDQAPDESPKLKSSSETSVHCTSYRGVPASKPEPARAKAKLSKFSIPKQGEESRSGETNSCVEEIIREMTWLPPLSAIQAPGKVEPTKFPFPNKDSQLVSSGHNNPKKGDAEPESPDSGTSNTSMLEDDLKLSSDEEENEQQAAQRTALRALSDSAVVQQPNCRTSVPSSKGSSSSSSSGSSSSSSDSESSSGSDSETESSSSESEGSKPPHFSSPEAEPASSNKWQLDKWLNKVNPHKPPILIQNESHGSESNQYYNPVKEDVQDCGKVPDVCQPSLREKEIKSTCKEEQRPRTANKAPGSKGVKQKSPPAAVAVAVSAAAPPPAVPCAPAENAPAPARRSAGKKPTRRTERTSAGDGANCHRPEEPAAADALGTSVVVPPEPTKTRPCGNNRASHRKELRSSVTCEKRRTRGLSRIVPKSKEFIETESSSSSSSSDSDLESEQEEYPLSKAQTVAASASSGNDQRLKEAAANGGSGPRAPVGSINARTTSDIAKELEEQFYTLVPFGRNELLSPLKDSDEIRSLWVKIDLTLLSRIPEHLPQEPGVLSAPATKDSESAPPSHTSDTPAEKALPKSKRKRKCDNEDDYREIKKSQGEKDSSSRLATSTSNTLSANHCNMNINSVAIPINKNEKMLRSPISPLSDASKHKYTSEDLTSSSRPNGNSLFTSASSSKKPKADSQLQPHGGDLTKAAHNNSENIPLHKSRPQTKPWSPGSNGHRDCKRQKLVFDDMPRSADYFMQEAKRMKHKADAMVEKFGKALNYAEAALSFIECGNAMEQGPMESKSPYTMYSETVELIRYAMRLKTHSGPNATPEDKQLAALCYRCLALLYWRMFRLKRDHAVKYSKALIDYFKNSSKAAQAPSPWGASGKSTGTPSPMSPNPSPASSVGSQGSLSNASALSPSTIVSIPQRIHQMAANHVSITNSILHSYDYWEMADNLAKENREFFNDLDLLMGPVTLHSSMEHLVQYSQQGLHWLRNSAHLS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
145PhosphorylationVQQSKRGTMGWQKAG
ECCCCCCCCCCHHCC
19.2868735075
248PhosphorylationQDQAPDESPKLKSSS
CCCCCCCCCCCCCCC
34.4122199227
271AcetylationYRGVPASKPEPARAK
CCCCCCCCCCCHHHH
56.3525953088
273PhosphorylationGVPASKPEPARAKAK
CCCCCCCCCHHHHHH
56.1627251275
278AcetylationKPEPARAKAKLSKFS
CCCCHHHHHHHHHCC
40.27164463
280AcetylationEPARAKAKLSKFSIP
CCHHHHHHHHHCCCC
53.22164467
285PhosphorylationKAKLSKFSIPKQGEE
HHHHHHCCCCCCCCC
41.5424719451
310PhosphorylationEEIIREMTWLPPLSA
HHHHHHHCCCCCHHH
21.0618669648
316PhosphorylationMTWLPPLSAIQAPGK
HCCCCCHHHCCCCCC
29.1518669648
336PhosphorylationFPFPNKDSQLVSSGH
CCCCCCCCCCCCCCC
27.3329083192
340PhosphorylationNKDSQLVSSGHNNPK
CCCCCCCCCCCCCCC
38.9129083192
341PhosphorylationKDSQLVSSGHNNPKK
CCCCCCCCCCCCCCC
36.2718669648
393PhosphorylationRTALRALSDSAVVQQ
HHHHHHHHHCCEECC
28.6514891069
395PhosphorylationALRALSDSAVVQQPN
HHHHHHHCCEECCCC
21.4228450419
406PhosphorylationQQPNCRTSVPSSKGS
CCCCCCCCCCCCCCC
16.8126657352
409PhosphorylationNCRTSVPSSKGSSSS
CCCCCCCCCCCCCCC
42.3927251275
414PhosphorylationVPSSKGSSSSSSSGS
CCCCCCCCCCCCCCC
42.8010405697
418PhosphorylationKGSSSSSSSGSSSSS
CCCCCCCCCCCCCCC
40.4424719451
431PhosphorylationSSSDSESSSGSDSET
CCCCCCCCCCCCCCC
34.3727251275
434PhosphorylationDSESSSGSDSETESS
CCCCCCCCCCCCCCC
39.6527251275
436PhosphorylationESSSGSDSETESSSS
CCCCCCCCCCCCCCC
48.3810405707
440PhosphorylationGSDSETESSSSESEG
CCCCCCCCCCCCCCC
42.8310405717
524AcetylationSLREKEIKSTCKEEQ
HHCHHHHHHHCCHHH
40.587665143
535PhosphorylationKEEQRPRTANKAPGS
CHHHCCCCCCCCCCC
36.9546160169
538AcetylationQRPRTANKAPGSKGV
HCCCCCCCCCCCCCC
54.1925953088
542PhosphorylationTANKAPGSKGVKQKS
CCCCCCCCCCCCCCC
25.7746160151
543AcetylationANKAPGSKGVKQKSP
CCCCCCCCCCCCCCC
73.8925953088
549PhosphorylationSKGVKQKSPPAAVAV
CCCCCCCCCCHHHHH
33.3582900377
559PhosphorylationAAVAVAVSAAAPPPA
HHHHHHHHCCCCCCC
11.4928122231
574PhosphorylationVPCAPAENAPAPARR
CCCCCCCCCCCCHHH
54.0224719451
626AcetylationVVPPEPTKTRPCGNN
ECCCCCCCCCCCCCC
53.9322361491
643PhosphorylationSHRKELRSSVTCEKR
HHHHHHHHHCCHHHH
41.6124702127
644PhosphorylationHRKELRSSVTCEKRR
HHHHHHHHCCHHHHH
18.2724702127
646PhosphorylationKELRSSVTCEKRRTR
HHHHHHCCHHHHHHC
19.5224702127
673PhosphorylationIETESSSSSSSSDSD
HCCCCCCCCCCCCCH
35.8730576142
676PhosphorylationESSSSSSSSDSDLES
CCCCCCCCCCCHHHH
39.8630576142
679PhosphorylationSSSSSSDSDLESEQE
CCCCCCCCHHHHHHH
46.1546160157
683PhosphorylationSSDSDLESEQEEYPL
CCCCHHHHHHHHCCC
52.4530576142
730O-linked_GlycosylationVGSINARTTSDIAKE
CCCCCCCCHHHHHHH
28.3930379171
755PhosphorylationFGRNELLSPLKDSDE
CCCCCCCCCCCCHHH
40.5919369195
773PhosphorylationLWVKIDLTLLSRIPE
HHHHHHHHHHHCCCC
23.1646160175
780PhosphorylationTLLSRIPEHLPQEPG
HHHHCCCCCCCCCCC
56.5424719451
806PhosphorylationSAPPSHTSDTPAEKA
CCCCCCCCCCHHHHH
33.7828348404
808PhosphorylationPPSHTSDTPAEKALP
CCCCCCCCHHHHHCC
24.9428348404
847PhosphorylationDSSSRLATSTSNTLS
CCCCCCCCCCCCCCC
36.8150563859
852PhosphorylationLATSTSNTLSANHCN
CCCCCCCCCCCCCCC
23.1268737265
854PhosphorylationTSTSNTLSANHCNMN
CCCCCCCCCCCCCCC
25.6168737271
864PhosphorylationHCNMNINSVAIPINK
CCCCCCCEEEEECCC
14.7750563865
878PhosphorylationKNEKMLRSPISPLSD
CCCHHHCCCCCCCCH
23.7130266825
881PhosphorylationKMLRSPISPLSDASK
HHHCCCCCCCCHHHC
24.1530266825
884PhosphorylationRSPISPLSDASKHKY
CCCCCCCCHHHCCCC
34.2230266825
887PhosphorylationISPLSDASKHKYTSE
CCCCCHHHCCCCCCC
40.0428450419
903PhosphorylationLTSSSRPNGNSLFTS
CCCCCCCCCCCCCCC
62.2624719451
906PhosphorylationSSRPNGNSLFTSASS
CCCCCCCCCCCCCCC
26.6824719451
921PhosphorylationSKKPKADSQLQPHGG
CCCCCCCCCCCCCCH
37.3424719451
931PhosphorylationQPHGGDLTKAAHNNS
CCCCHHHHHHHHCCC
24.3124719451
938PhosphorylationTKAAHNNSENIPLHK
HHHHHCCCCCCCCCC
37.02113310201
946PhosphorylationENIPLHKSRPQTKPW
CCCCCCCCCCCCCCC
38.1424719451
950PhosphorylationLHKSRPQTKPWSPGS
CCCCCCCCCCCCCCC
41.5846160181
954PhosphorylationRPQTKPWSPGSNGHR
CCCCCCCCCCCCCCC
28.1046160163
956PhosphorylationQTKPWSPGSNGHRDC
CCCCCCCCCCCCCCC
28.3824719451
957PhosphorylationTKPWSPGSNGHRDCK
CCCCCCCCCCCCCCC
42.9282900383
967UbiquitinationHRDCKRQKLVFDDMP
CCCCCCCCEEECCCC
51.13-
979PhosphorylationDMPRSADYFMQEAKR
CCCHHHHHHHHHHHH
10.7324719451
985UbiquitinationDYFMQEAKRMKHKAD
HHHHHHHHHHHHHHH
52.88-
1093PhosphorylationYSKALIDYFKNSSKA
HHHHHHHHHHCCCCC
14.9528270605
1097PhosphorylationLIDYFKNSSKAAQAP
HHHHHHCCCCCCCCC
33.5328270605
1098PhosphorylationIDYFKNSSKAAQAPS
HHHHHCCCCCCCCCC
35.3928270605
1105PhosphorylationSKAAQAPSPWGASGK
CCCCCCCCCCCCCCC
35.9828450419
1121PhosphorylationTGTPSPMSPNPSPAS
CCCCCCCCCCCCCCC
25.5527251275
1125PhosphorylationSPMSPNPSPASSVGS
CCCCCCCCCCCCCCC
39.4728348404
1129PhosphorylationPNPSPASSVGSQGSL
CCCCCCCCCCCCCCC
32.3846160145
1130PhosphorylationNPSPASSVGSQGSLS
CCCCCCCCCCCCCCC
8.7224719451
1146PhosphorylationASALSPSTIVSIPQR
CCCCCHHHHCCHHHH
28.8727251275

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of AFF3_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of AFF3_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of AFF3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of AFF3_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of AFF3_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-881, AND MASSSPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-393; SER-755 ANDSER-881, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-881, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-310 AND SER-316, ANDMASS SPECTROMETRY.

TOP